Stocklytics Platform
Bluejay Diagnostics
BJDX69
$3.97arrow_drop_down0.12%-$0.00
NASDAQ - As of Mar 14, 5:57 AM EDT Market Closed
High Growth
Penny Stock
BJDX69

$3.97

arrow_drop_down0.12%

Performance History

Chart placeholder
Key Stats
Open$3.92
Prev. Close$3.98
EPS-804.00
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$2.20M
PE Ratio-
LOWHIGH
Day Range3.77
3.97
52 Week Range0.06
38.96
Ratios
P/B Ratio0.33
Revenue-
Operating M. %0.00%
Earnings$0.00
Earnings Growth %-7.07%
EBITDA Margin %-
ROE %-138.78%
EPS-804.00

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Predicted: just now

info

Analyzed by 1 Wall Street experts, Bluejay Diagnostics's 12-month projections average at $10.00, spanning from a high of $10.00 to a low of $10.00. This signifies an 151.57% shift from the current price of $3.97.

Analyst Ratings

no data available for Analyst Ratings

There's no data available for Analyst Ratings

Last updated: -

Total: -

Correlated Companies

Price$803.54
Perf. (24h)arrow_drop_up0.25%$2.04
Market Cap$720.01B
Price$481.99
Perf. (24h)arrow_drop_up0.09%$0.47
Market Cap$444.64B
Price$163.47
Perf. (24h)arrow_drop_up0.05%$0.09
Market Cap$397.30B
Price$212.43
Perf. (24h)arrow_drop_up0.41%$0.87
Market Cap$373.46B

About Bluejay Diagnostics (BJDX)

Bluejay Diagnostics, Inc. (BJDX) is a leading provider of diagnostic instruments and testing solutions in the healthcare industry. The company specializes in the development and manufacture of innovative diagnostic devices that aid in the detection and monitoring of various diseases and conditions. With a strong focus on research and development, Bluejay Diagnostics is continuously striving to improve the accuracy and efficiency of diagnostic testing. The company's commitment to innovation has positioned it as a key player in the rapidly growing diagnostics market.
Bluejay Diagnostics has a rich history of delivering reliable and high-quality diagnostic instruments to healthcare professionals around the world. The company's products are known for their accuracy, ease of use, and advanced features. Bluejay Diagnostics offers a wide range of instruments and testing solutions, including blood analyzers, molecular diagnostic systems, and point-of-care testing devices. These products are designed to meet the needs of various healthcare settings, from hospitals and clinics to research laboratories and pharmacies.
Show more
Sector
Healthcare
Industry
Medical Devices
CEO
Mr. Indranil Dey
Headquarters
Acton
Employees
16
Exchange
NASDAQ
add Bluejay Diagnostics to watchlist

Keep an eye on Bluejay Diagnostics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Bluejay Diagnostics's (BJDX) price per share?

The current price per share for Bluejay Diagnostics (BJDX) is $3.98. The stock has seen a price change of -$0 recently, indicating a -0.13% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Bluejay Diagnostics (BJDX)?

For Bluejay Diagnostics (BJDX), the 52-week high is $38.96, which is 880.13% from the current price. The 52-week low is $0.06, the current price is 6.12K% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Bluejay Diagnostics (BJDX) a growth stock?

Bluejay Diagnostics (BJDX) has shown an average price growth of -1.65% over the past three years. It has received a score of 92 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Bluejay Diagnostics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Bluejay Diagnostics (BJDX) stock price performance year to date (YTD)?

As of the latest data, Bluejay Diagnostics (BJDX) has a year-to-date price change of -18.38%. Over the past month, the stock has experienced a price change of 6.57%. Over the last three months, the change has been -14.15%. Over the past six months, the figure is -47.46%.
help

Is Bluejay Diagnostics (BJDX) a profitable company?

Bluejay Diagnostics (BJDX) has a net income of -$9.95M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$10.31M. Furthermore, the EBITDA is -$7.99M.
help

What is the market capitalization of Bluejay Diagnostics (BJDX)?

Bluejay Diagnostics (BJDX) has a market capitalization of $2.2M. The average daily trading volume is 3.81, indicating the stock's liquidity and investor engagement.

Take Your Investments to a Whole New Level